VF
NKGNW

Virtu Financial’s NKGen Biotech, Inc. Warrants NKGNW Stock Holding History

Virtu Financial’s Portfolio NKGNW Stock Details NKGNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-13,631
Closed -$2K – 2004
2024
Q1 		$2K Buy
+13,631
New +$1.55K ﹤0.01% 1323

Other funds holding NKGNW

RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
EAM
Exos Asset Management New York $2.32K AUM 108.13% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
TCA
Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return

Virtu Financial's NKGNW Position: Q2 2024 in Review

Virtu Financial sold out of NKGen Biotech, Inc. Warrants (NKGNW) in Q2 2024, closing a stake of 13,631 shares — an estimated $2K sold.

Virtu Financial first reported a position in NKGNW in Q1 2024 and held it in 1 quarter. The position peaked at $2K in Q1 2024. 31 funds tracked by Wall St. Rank hold NKGNW as of Q2 2024.

  • Virtu Financial reported no remaining NKGen Biotech, Inc. Warrants position as of Q2 2024 after selling out during the quarter.
  • Virtu Financial sold 13,631 NKGen Biotech, Inc. Warrants shares in Q2 2024, an estimated $2K.
  • Virtu Financial first reported a position in NKGen Biotech, Inc. Warrants in Q1 2024 and held it in 1 quarter.
  • Virtu Financial's NKGen Biotech, Inc. Warrants position peaked at $2K in Q1 2024.
  • 31 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Warrants as of Q2 2024.

Based on Virtu Financial's 13F filing for Q2 2024, filed 9 Aug 2024.